Colorectal Cancer Blood-Based Biomarkers
Mortality and morbidity associated with colorectal cancer (CRC) are increasing globally, partly due to lack of early detection of the disease. The screening is usually performed with colonoscopy, which is invasive and unpleasant, discouraging participation in the screening. As a source of noninvasiv...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/2195361 |
id |
doaj-b8270b49e50a4925a8083e1697810bd6 |
---|---|
record_format |
Article |
spelling |
doaj-b8270b49e50a4925a8083e1697810bd62020-11-24T22:31:25ZengHindawi LimitedGastroenterology Research and Practice1687-61211687-630X2017-01-01201710.1155/2017/21953612195361Colorectal Cancer Blood-Based BiomarkersNina Hauptman0Damjan Glavač1Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaDepartment of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaMortality and morbidity associated with colorectal cancer (CRC) are increasing globally, partly due to lack of early detection of the disease. The screening is usually performed with colonoscopy, which is invasive and unpleasant, discouraging participation in the screening. As a source of noninvasive and easily accessible biomarkers, liquid biopsies are emerging. Blood-based biomarkers have the potential as diagnostic and prognostic tool in CRC. Early stage detection of CRC with high sensitivity and specificity would likely lead to higher participation in the screening test. It would also improve the prognosis of the disease and improve the recurrence risk. In this review, we summarize the potential biomarkers for early detection and monitoring of CRC.http://dx.doi.org/10.1155/2017/2195361 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nina Hauptman Damjan Glavač |
spellingShingle |
Nina Hauptman Damjan Glavač Colorectal Cancer Blood-Based Biomarkers Gastroenterology Research and Practice |
author_facet |
Nina Hauptman Damjan Glavač |
author_sort |
Nina Hauptman |
title |
Colorectal Cancer Blood-Based Biomarkers |
title_short |
Colorectal Cancer Blood-Based Biomarkers |
title_full |
Colorectal Cancer Blood-Based Biomarkers |
title_fullStr |
Colorectal Cancer Blood-Based Biomarkers |
title_full_unstemmed |
Colorectal Cancer Blood-Based Biomarkers |
title_sort |
colorectal cancer blood-based biomarkers |
publisher |
Hindawi Limited |
series |
Gastroenterology Research and Practice |
issn |
1687-6121 1687-630X |
publishDate |
2017-01-01 |
description |
Mortality and morbidity associated with colorectal cancer (CRC) are increasing globally, partly due to lack of early detection of the disease. The screening is usually performed with colonoscopy, which is invasive and unpleasant, discouraging participation in the screening. As a source of noninvasive and easily accessible biomarkers, liquid biopsies are emerging. Blood-based biomarkers have the potential as diagnostic and prognostic tool in CRC. Early stage detection of CRC with high sensitivity and specificity would likely lead to higher participation in the screening test. It would also improve the prognosis of the disease and improve the recurrence risk. In this review, we summarize the potential biomarkers for early detection and monitoring of CRC. |
url |
http://dx.doi.org/10.1155/2017/2195361 |
work_keys_str_mv |
AT ninahauptman colorectalcancerbloodbasedbiomarkers AT damjanglavac colorectalcancerbloodbasedbiomarkers |
_version_ |
1725737151266553856 |